The KRASG12C inhibitors in lung cancer therapy

• Prif Awduron: Maciej Jędrak (Awdur), Karolina Niekurzak (Awdur), Joanna Kania (Awdur), Maciej Józefiak (Awdur), Piotr Sobkiewicz (Awdur), Krzysztof Kania (Awdur)
• Fformat: Llyfr
• Cyhoeddwyd: Kazimierz Wielki University, 2023-09-01T00:00:00Z.
• Pynciau: article
• Mynediad Ar-lein: Connect to this object online.

Introduction: Lung cancer is characterized by the highest mortality among cancers and is the second most frequently diagnosed type of cancer in the world. Targeted therapies are a promising therapeutic option for patients with this disease, however, one of the most common and most malignant mutation...